Pharma sector stocks today, July 29: J.B. Chemicals falls 3.73%, Divis Laboratories gains 1.84%, Glenmark Pharma up 1.43%
NiveshIQ
NSE: JBCHEPHARM · Chemicals
J.B. Chemicals & Pharmaceuticals Ltd.
₹2,408.90▼ ₹97.10 (-3.87%)
Price Chart · Daily closes
1Y
6M
3M
1M
1W
1D
⚡ Intelligence Signals
5 active
🟢 Bullish Earnings Catalyst
📊 RS Laggard (5D)
🔄 Sector Sweep
⚡ Signals Aligned
📉 Pullback
NiveshIQ has detected 5 active signals on JBCHEPHARM. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeExpected Move
1D / 1W / 1M range derived from news, fundamentals & technicals
1 Day
±1.8%
1 Week
±4.2%
1 Month
±9.6%
Confidence Score
Based on historical directional & magnitude accuracy for this stock
74
/ 100
About J.B. Chemicals & Pharmaceuticals Ltd.
J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM) is a leading Indian pharmaceutical company with a diversified product portfolio, including pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API). The company's API product portfolio includes diclofenac sodium, diethylamine, acid, and potassium; and nifedipine, atenolol, and cilnidipine; and ciprofloxacin, cetirizine, and meclizine HCI. JBCHEPHARM offers a range of pharmaceutical dosage forms, including tablets, capsules, liquids, gels, lozenges, creams, injectables, powder, cold rubs, eye drops, and troches. The company provides its products to various therapeutic segments, including gastroenterology, anti-infectives, wound care, neonatology and pediatrics, genecology, dental, vitamins and minerals,
Financial Highlights
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹3,485 Cr +124.10% | ₹3,917 Cr +12.40% | ₹4,148 Cr +5.90% |
| EBITDA Margin | 25.74% | 26.35% | 28.15% |
| Net Profit | ₹553.00 Cr +185.10% | ₹660.00 Cr +19.30% | ₹709.47 Cr +7.50% |
| EPS | ₹35.65 | ₹42.44 | ₹45.16 |
Annual figures in Indian Rupees (Crores). Source: BSE filings.
Recent News
Torrent Pharma lists 4.19 crore shares from JB Chemicals merger on July 28
JB Chemicals & Pharmaceuticals Ltd. Revenue Breakdown – NSE:JBCHEPHARM
🔒
+ 3 more stories about J.B. Chemicals & Pharmaceuticals Ltd.
Full news feed with AI impact summaries, synced in real time.
Sign up free — it's instantStrategic Outlook
- Q4FY26 results: revenue ₹904 Cr, PAT ₹101 Cr, EPS ₹6.35, EBITDA margin 23.6%. Growth context: revenue YoY -4.7%, PAT YoY -30.6%, revenue QoQ -15.1%, PAT QoQ -48.8%. Street verdict: strong miss, revenue surprise -13.1%, PAT surprise -24.8%.
Recent corporate activity highlights product launches, approvals, and therapy-mix improvement as the primary near-term g...
FY26 (last completed FY): revenue ₹4, 148 Cr, PAT ₹709 Cr, EBITDA margin 28.1%, EPS ₹45.16. Year-on-year: revenue YoY +5...
🔒
+ 3 more outlook points
Growth drivers, key risks, and upcoming catalysts — unlocked free.
Sign up free — it's instantEverything you unlock with a free account
⚡Intelligence Signals — AI-detected patterns across news, earnings & technicals
📈Price Chart — 1D to 1Y daily closes for JBCHEPHARM
🎯Expected Move — 1D / 1W / 1M range from news, fundamentals & technicals
🧠Confidence Score — Historical directional & magnitude accuracy for this stock
🎙Analyst Target Price — Consensus target with buy / hold / sell breakdown
📰Full News Feed — All stories synced in real time with AI impact summaries
🔭Strategic Outlook — Growth drivers, risks & upcoming catalysts
📊Watchlist & Portfolio — Track JBCHEPHARM alongside your other holdings
Unlock full JBCHEPHARM research — free
No credit card · No trial · Always free to start
Frequently Asked Questions
What AI signals does NiveshIQ provide for J.B. Chemicals & Pharmaceuticals Ltd.?
NiveshIQ detects active intelligence signals for J.B. Chemicals & Pharmaceuticals Ltd. (JBCHEPHARM) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for J.B. Chemicals & Pharmaceuticals Ltd.?
J.B. Chemicals & Pharmaceuticals Ltd. operates in the Chemicals sector with a market capitalisation of ₹3,456,026.2L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.